Analysis of the effectiveness of antiangiogenic therapy in the complex treatment of patients with diabetic macular edema

Currently, priority in the treatment of diabetic macular edema (DME) with use from inhibitors of vascular endothelial growth factor (VEGF), the effectiveness of this method has been proven by multicenter researches. The aim of our research is investigation the effectiveness of usage for antiangiogenic therapy in the complex treatment of patients with diabetic macular edema. Material and methods. We analysed with refractory laser photocoagulation resistant DME in 61 eyes of 49 patients for effectiveness of this drug. Ophthalmological examinations in patients (visometry, biomicroscopy, non-contact tonometry, optical coherence tomography (OCT), refractometry and color photographing of fundus) were performed the day after the injection, then on the 2nd, 4th, 8th, 12th , 16th, 20th and 24th week and next every 3 months until the end of the observation period. Results and conclusion. The competent use of drugs from this group in compliance with the developed schemes and techniques for intravitreal injection, well-defined indications for repeated injections, as well as compact dynamic monitoring of patients can become the key to success in maintaining and improving visual functions in patients with diabetic macular edema (DME).